KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms KYSS
- Sponsors Bayer
- 02 Aug 2018 Planned End Date changed from 31 Oct 2019 to 29 Nov 2019.
- 02 Aug 2018 Planned primary completion date changed from 31 Jul 2019 to 31 Aug 2019.
- 11 Feb 2018 Planned number of patients changed from 1100 to 1200.